Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study
Kane, Michael A C, Brandt, Fredric, Rohrich, Rod J, Narins, Rhoda S, Monheit, Gary D, Huber, M Barbara
Published in Plastic and reconstructive surgery (1963) (01.11.2009)
Published in Plastic and reconstructive surgery (1963) (01.11.2009)
Get more information
Journal Article
Time to Onset of Response of AbobotulinumtoxinA in the Treatment of Glabellar Lines: A Subset Analysis of Phase 3 Clinical Trials of a New Botulinum Toxin Type A
SCHLESSINGER, JOEL, MONHEIT, GARY, KANE, MICHAEL A.C., MENDELSOHN, NAOMI
Published in Dermatologic surgery (01.10.2011)
Published in Dermatologic surgery (01.10.2011)
Get full text
Journal Article
Optimizing Outcomes When Treating Glabellar Lines
Solish, Nowell, Bertucci, Vince, Green, Jeremy B, Kane, Michael A C
Published in Aesthetic surgery journal (14.06.2023)
Published in Aesthetic surgery journal (14.06.2023)
Get full text
Journal Article
Algorithmic Prediction of Health-Care Costs
Bertsimas, Dimitris, Bjarnadottir, Margret V, Kane, Michael A, Kryder, J. Christian, Pandey, Rudra, Vempala, Santosh, Wang, Grant
Published in Operations research (01.11.2008)
Published in Operations research (01.11.2008)
Get full text
Journal Article
Heterogeneity of crow's feet line patterns in clinical trial subjects
Kane, Michael A C, Cox, Sue Ellen, Jones, Derek, Lei, Xiaofang, Gallagher, Conor J
Published in Dermatologic surgery (01.04.2015)
Published in Dermatologic surgery (01.04.2015)
Get more information
Journal Article